Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Notice of Intent to Award to a Single Source

Active
PCA-NIDCD-09517Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health Office of the Director Office of Acquisitions intends to award a single-source contract to the University of Illinois School of Chemical Sciences for the procurement of K101 and K110 pellets. These pellets are required by the National Institute on Deafness and Other Communication Disorders to ensure a superior steady-state, slow-release of study compounds over 90-day periods. The government has identified the University of Illinois as the sole source capable of providing the necessary quality and consistency required to maintain the integrity of ongoing study data, as commercial alternatives have proven unmatched. This notice serves as a pre-solicitation under the authority of 41 U.S.C. 3204(b)(2), and is not a formal request for proposal. However, interested vendors may submit capability statements and past performance documentation to Christine Biser by September 16, 2026, referencing solicitation PCA-NIDCD-09517. The government will evaluate these submissions to determine if the procurement should be conducted on a competitive basis, though the final decision remains at the discretion of the agency.

General Info

NIH single-source contract to University of Illinois for K101 and K110 pellets.

Agency

Department Of Health And Human Services → National Institutes Of HealthView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

IL, 61801, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeBethesda, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
View Agency Profile
Office AddressBethesda, MD, 20892, USA
Contacts
Christine Biser Contracting Officer

Full Description

Show more

Notice of Intent to Award to a Single Source - University of Illinois School of Chemical Sciences K101 and K110 pellets




This is a Notice of Intent (NOI), not a request for proposal. The National Institutes of Health Office of the Director Office of Acquisitions intends to negotiate on an other-than-full-and-open competition basis with the University of Illinois at Urbana Champaign, School of Chemical Sciences, 505 S. Mathews, Urbana, IL  61801, USA for a requirement of the National Institute on Deafness and Other Communication Disorders (NIDCD).  NIDCD needs slow-release of study compounds K101 and K110 in pellets that achieve superior steady-state release for 90-day study periods.  It is critical to the ongoing studies that the exceptionally even release of study compound in the University of Illinois product not be varied by introducing a new supplier.  The quality of the University of Illinois pellets’ compound release rates has been tested and unmatched by similar pellets obtained on the commercial marketplace and provides critical data for these ongoing studies.  To preserve the study data’s integrity, the supplier must remain the same. 


While this pre-solicitation does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that the University of Illinois is the inventor and manufacturer of the required product currently being utilized by NIDCD per compatibility requirements. However, vendors who believe that they can provide the capability required to fully meet the Government's requirement may submit a capabilities statement, including past performance, in writing to the identified point of contact prior to the closing date and time of this notice. Interested parties should clearly address the obstacles of continuing studies with a non-University of Illinois School of Chemical Sciences product.  Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement by referencing “PCA-NIDCD-09517.”


The statutory authority for this sole source requirement is 41 U.S.C. 3204(b)(2) as implemented by FAR Overhaul 12.102(a) only one source is available. THIS IS NOT A REQUEST FOR PROPOSAL.


All responsible sources that could provide comparable products may submit a capability statement via email to Christine Biser at:


ChristineBi@mail.nih.gov by 12:00 pm EASTERN Daylight Time, Wednesday, September 16, 2026.


Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.


Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Christine Biser at ChristineBi@mail.nih.gov.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)
Solicitation # W911SR-26-9-CADENCC
The Department of the Army, through the Army Contracting Command Edgewood Contracting Division and the Joint Project Lead Enabling Technologies, is seeking preproposals for the Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability project. This initiative aims to accelerate clinical trial startups for CBRN defense readiness by implementing Master Protocols, utilizing innovative technologies for decentralized trial operations, and establishing a pre-positioned clinical trial site network. The project will primarily focus on Phase I and Phase II clinical trials for early treatment products, post-exposure prophylaxis, and pre-exposure prophylaxis, including those under the Animal Rule. This opportunity is issued under 10 USC 4022 Other Transaction Authority for a prototype project, with the potential for non-competitive follow-on production contracts for successful performers. Preproposals are due by 1500 hours on September 17, 2026, and must be limited to 10 pages. Evaluation will be based on technical merit, military relevance, technology readiness level 4 or above, regulatory compliance with FDA guidelines, and best overall value. Prospective awardees must be registered in the System for Award Management database.
W6QK Acc-Apg

POSTED

about 11 hours ago

DEADLINE

in 3 days
View Details
NAICS: 541714
New
Federal
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation # 75A50126R00001_RFP_NPIVS_27
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures (MCMs) for Pandemic Influenza Preparedness and Response Program. The primary objective is to maintain a permanent readiness posture and a commercially sustainable warm-base production capacity for the rapid manufacture of vaccines, antigens, and adjuvants during public health emergencies. Contractors are required to produce these countermeasures against influenza and other viruses with pandemic potential, generate and submit all necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data to the FDA, and support rapid regulatory decisions. To be eligible, offerors must hold a U.S. influenza vaccine license or have developed an influenza vaccine as evidenced by a Biologics License Application submission. The contract is structured as an IDIQ with a five-year base period and a potential five-year option period, totaling a possible 120-month ordering period. Award decisions will be based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology, with a significant emphasis on capabilities. Key requirements include strict adherence to CGMP guidelines, the implementation of comprehensive business and supply continuity plans, and the submission of surge manufacturing and supply chain readiness assessments. Deliverables include the preparation of candidate vaccine viruses and the management of complex logistics, including temperature-controlled shipping and specific packaging standards. Payment is processed quarterly via the Department of Treasury Invoice Processing Platform.
Barda - Aspr / Daappo / Barda Dcma

POSTED

3 days ago

DEADLINE

in 2 months
View Details
NAICS: 541714
New
Federal
Industry Day: DARPA Documentation & Decision Support Sprint (D2)
Solicitation # DARPA-SN-26-118
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) has issued Special Notice DARPA-SN-26-118 to announce a virtual Industry Day on September 22, 2026, for the Documentation and Decision Support Sprint (D2). This initiative aims to advance combat medicine by developing autonomous solutions that use passive sensor data, such as audio, video, and accelerometry, to assist untrained individuals in delivering tactical combat casualty care during the first 20 minutes of treatment. The project is divided into two primary lanes: Lane 1 focuses on the autonomous population of digital DD Form 1380 TCCC Cards, and Lane 2 focuses on providing real-time clinical decision support for non-medics based on Committee on Tactical Combat Casualty Care and Joint Trauma System Clinical Practice Guidelines. This announcement is an informational notice and not a formal solicitation for proposals or abstracts. Interested U.S. entities and citizens must register for the Industry Day by September 20, 2026, at 5:00 PM ET, with attendance limited to the first 1,000 registrants. While no formal proposals are being accepted, prospective competitors may submit one-page teaming profiles to D2Sprint@darpa.mil by September 22, 2026, to facilitate partnership arrangements. The D2 effort will be conducted at the unclassified level and will utilize targeted prize incentives to catalyze technological advancements. Technical and administrative inquiries are directed to Dr. Jeremy Pamplin and the D2Sprint email address.
Defense Advanced Research Projects Agcy

POSTED

3 days ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
DARPA Surgical Competition (DSC) Industry Day
Solicitation # DARPA-SN-26-125
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is hosting an Industry Day for the DARPA Surgical Competition (DSC) on September 22, 2026, from 9:00 AM to 12:30 PM ET. This hybrid event, held in Arlington, Virginia, and virtually, aims to introduce a competition focused on developing a minimum viable product for scalable, autonomous robotic trauma surgery systems. The competition is designed to establish the state of the art for open robotic trauma surgery and identify technologies for autonomous surgical assistance. Performance will be evaluated through three primary lanes: Component Gates, which assess system safety and autonomy across medical knowledge, physical capability, and rapid learning; Surgical Collaboration, which tests the platform's ability to work alongside a human surgeon; and Surgical Independence, which evaluates the system's ability to plan and execute end-to-end trauma procedures without assistance. While this special notice is not a formal request for proposals, interested parties are invited to participate by registering and optionally submitting materials by September 18, 2026. These materials include a single-slide landscape PDF for a three-minute lightning talk and a teaming profile detailing technical competencies and collaboration goals. All submissions must contain only unclassified, non-proprietary information. Technical and administrative inquiries are managed by Program Manager Jeremy Pamplin via the SurgicalCompetition@darpa.mil email address.
Defense Advanced Research Projects Agcy

POSTED

3 days ago

DEADLINE

in 2 days
View Details
NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
FDA Office Of Acq Grant Svcs

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 541714
New
Federal
Hypoxia Chamber Services
Solicitation # 80JSC026Q0008
NASA Johnson Space Center is soliciting combined synopsis and request for quotations under solicitation 80JSC026Q0008 for Hypoxia Chamber Services to support the Artemis Program. The objective is to investigate the physiological, cognitive, and clinical effects of mild hypobaric hypoxia through two 7-day test protocols involving continuous habitation for six subjects at air equivalent altitudes of 7,000 and 9,500 feet. The scope of work encompasses the provision of infrastructure, personnel, training, materials, and operational support. The contract is structured as a firm fixed price agreement with a base period from September 15, 2026, to September 30, 2027, and multiple option periods extending through March 1, 2030. The acquisition is open to all responsible sources under NAICS code 541714, with a size standard of 1,000 employees. Evaluation is based on a trade-off process where technical acceptability and past performance are significantly more important than price. Proposals must be submitted via email to the designated points of contact by October 1, 2026, following an extension granted in Amendment 0004. Key requirements include the submission of FAR 52.212-3 representations and certifications and adherence to specific submission criteria regarding team qualifications and risk assessment. The contract also incorporates strict guidelines regarding the protection of sensitive information and restrictions on funding activities with China.
NASA Johnson Space Center

POSTED

4 days ago

DEADLINE

in 17 days
View Details
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting quotes under solicitation 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity to support Artemis mission planning. The base requirement consists of three test days, with a minimum of two subjects per day, collecting and recording data according to research protocols. The contract also includes six optional work items, including additional test days, inflight-like treatment preparation, elevated metabolic rate testing, pharmaceutical-enhanced prebreathe, and body temperature studies. The base period of performance runs from September 1, 2026, to September 30, 2027, with various option periods extending through March or September 2029. This is a small business set-aside acquisition under NAICS code 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule for subject throughput. Offerors must provide a price quotation using the provided pricing sheet, and quotes must remain valid for at least 90 days. Following several amendments, the final deadline for the submission of offers is October 1, 2026, at 1:00 p.m. Central Time. All submissions must be sent electronically to the designated points of contact.
NASA Johnson Space Center

POSTED

4 days ago

DEADLINE

in 17 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS